Study of mutant prevention concentrations of macrolide-resistant Streptococcus pneumoniae

邢茂; 刘同华; 王琴

您当前的位置：

首页 >

文章列表页 >

Study of mutant prevention concentrations of macrolide-resistant Streptococcus pneumoniae

更新时间：2026-01-09

- Study of mutant prevention concentrations of macrolide-resistant Streptococcus pneumoniae
- Journal of Army Medical University Vol. 31, Issue 13, Pages: 1299-1301(2009)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R378.12;R969;R978.15
- Published：2009
- 稿件说明：
移动端阅览
邢茂,刘同华,王琴.大环内酯类药物对肺炎链球菌的防耐药突变浓度的研究[J].陆军军医大学学报(原第三军医大学学报),2009,31(13):1299-1301.

　XING Mao,LIU Tong-hua,WANG Qin.Study of mutant prevention concentrations of macrolide-resistant Streptococcus pneumoniae[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(13):1299-1301.
邢茂,刘同华,王琴.大环内酯类药物对肺炎链球菌的防耐药突变浓度的研究[J].陆军军医大学学报(原第三军医大学学报),2009,31(13):1299-1301. DOI：

　XING Mao,LIU Tong-hua,WANG Qin.Study of mutant prevention concentrations of macrolide-resistant Streptococcus pneumoniae[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(13):1299-1301. DOI：

摘要

目的测定大环内酯类药物对肺炎链球菌的防耐药突变浓度（mutant prevention concentration

MPC），扩增突变选择窗(mutant selection window

MSW)内筛选的耐药突变体的耐药基因，以了解肺炎链球菌对大环内酯类药物耐药的发生机制。方法肉汤法富集10

CFU/ml ATCC49619，采用平板二倍稀释法测定罗红霉素和阿奇霉素对ATCC49619的最低抑菌浓度（minimal inhibitory concentration

MIC）、MIC

、初测MPC(Provisional MPC，MPCpr)以及MPC。PCR法扩增不同药物筛选出的耐药突变株的耐药基因ermB 和mefA并测序。结果罗红霉素和阿奇霉素对ATCC49619的MPC分别为0.80 μg/ml和0.51 μg/ml

细菌耐药选择指数（MPC/ MIC

）为5.0和3.9。筛选出的耐药突变株中扩增出ermB耐药基因。结论通过调整药物剂量，可以限制对大环内酯类耐药的肺炎链球菌突变体的富集。肺炎链球菌对大环内酯类药物耐药机制可能与携带ermB基因有关。

Abstract

Objective To detect the mutant prevention concentration (MPC) of macrolide resistant Streptococcus pneumoniae

to amplify the resistance gene of Streptococcus pneumoniae mutants selected in the mutant selection window (MSW)

and to investigate the mechanism in the resistance of Streptococcus pneumoniae to macrolides. Methods The Streptococcus pneumoniae strain ATCC49619 was enriched in broth

and the bacterial concentrations were adjusted to 10

colony forming units per milliliter. The minimal inhibitory concentr

ation (MIC)

MIC for 99 % of input cells (MIC

)

provisional MPC (MPCpr)

and MPC of roxithromycin and azithromycin for Streptococcus pneumoniae were determined by agar plate dilution method. The ermB and mefA of Streptococcus pneumoniae mutants selected in the MSW were obtained by PCR method and sequencing. Results The MPCs of roxithromycin and azithromycin for ATCC49619 were 0.80 μg/ml and 0.51 μg/ml

and the MPC/MIC

were 5.0 and 3.9. The ermB gene was detected in Streptococcus pneumoniae mutants selected in the MSW. Conclusion Adjustment of the drug dose may limit the enrichment of macrolide-resistant Streptococcus pneumoniae mutant. The mechanism in the resistance of Streptococcus pneumonia to macrolides may be associated with ermB genes carried.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

A live attenuated vaccine D39△CPS-TA with Pam2CSK4 as adjuvant elicits protection against pneumococcal infection in infant mice

Bioequivalence of positive ion azithromycin niosomes in different particle sizes

Protein expression localization, conservation analysis and biological functions of SpxB in Streptococcus pneumoniae

Azithromycin improves inflammation by suppressing functions of Th17 cells in a mouse allergic asthma model

Evaluation of cross-immune protection of PspA multivalent DNA vaccine against Streptococcus pneumoniae

Related Author

胥文春

尹一兵

吴盈盈

高松

赵家宁

宋志新

廖璞

曾令斌

Related Institution

No data

⁰